Youcare Pharmaceutical Group Co. Ltd. A

688658 · SHG · Healthcare / Biotechnology

10.99CNY-0.46 (-4.02%)

Price History

Full chart

Market Stats

Previous Close11.45

Open11.47

Day Range10.89 – 11.58

52-Week Range11.29 – 32.12

Volume8.95M

Market Cap6.32B

P/E (TTM)0.00

Forward P/E0.00

EPS-0.61

Dividend Yield0.00%

Beta0.64

50-Day Avg13.15

200-Day Avg17.92

About

Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder injection, pills, tablets, capsules, ointments, creams, granules, etc. The company provides drugs in various categories, including covering cardio-cerebrovascular, antivirals, central nervous system medication, turbidity and lipid-lowering, gastrointestinal system, anti-infection, endocrinology anti-tumour and other therapeutic areas. It also offers raw materials, pharmaceutical excipients, and formulations. Youcare Pharmaceutical Group Co., Ltd. was founded in 1988 and is headquartered in Beijing, China.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Fei Yu
Employees2.89K
HeadquartersNo. 6 Hongda Middle Road, Beijing, China, 100176, China
Websitehttps://www.youcareyk.com

Leadership

Mr. Fei YuMD, GM & Director · b. 1988
Ms. Yan LiuFinancial Director & CFO · b. 1972
Mr. Lei YangDeputy GM of R&D Center and Employee Representative Director · b. 1982
Mr. Genshen SongDeputy GM & Director · b. 1978
Ms. Xia WangDeputy GM & Director · b. 1988
Mr. Mengyang HaoBoard Secretary · b. 1986
Mr. Yusheng LiDeputy General Manager of Anhui Natural Pharmaceuticals · b. 1964
Jie FengAccounting Supervisor

Financials

Income Statement

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.70B	3.98B	4.29B	4.34B	4.97B	4.54B	4.20B	3.78B	2.45B
Growth (%)	-	+47.50%	+7.66%	+1.20%	+14.45%	-8.53%	-7.61%	-9.90%	-35.30%
Cost of Revenue	1.55B	1.62B	1.71B	1.50B	1.56B	1.67B	1.62B	1.64B	1.32B
Gross Profit	1.15B	2.37B	2.58B	2.84B	3.41B	2.87B	2.57B	2.14B	2.45B
Gross Margin	42.72%	59.41%	60.11%	65.34%	68.67%	63.25%	61.35%	56.62%	100.00%
Operating Expense	964.42M	2.04B	2.25B	2.34B	2.77B	2.51B	2.34B	1.98B	2.67B
Operating Income	188.95M	323.41M	328.06M	492.15M	636.82M	357.94M	231.75M	159.06M	-225.39M
Operating Margin	7.00%	8.12%	7.65%	11.34%	12.82%	7.88%	5.52%	4.21%	-9.21%
EBITDA	420.42M	483.66M	497.92M	655.34M	769.20M	509.45M	405.86M	371.85M	-32.03M
EBITDA Margin	15.57%	12.14%	11.61%	15.10%	15.49%	11.22%	9.67%	9.84%	-1.31%
Net Income	161.56M	267.95M	285.45M	442.14M	545.32M	335.18M	184.80M	123.72M	-253.84M
Net Income Margin	5.98%	6.73%	6.66%	10.19%	10.98%	7.38%	4.40%	3.27%	-10.38%
R&D	81.68M	98.10M	126.19M	127.89M	200.03M	344.42M	351.88M	374.31M	441.21M
R&D as % of Total Revenue	3.02%	2.46%	2.94%	2.95%	4.03%	7.58%	8.39%	9.90%	18.04%
Interest Expense	112.23M	42.63M	38.33M	28.57M	4.65M	5.78M	14.46M	23.53M	22.18M
Interest Expense % of Total Revenue	4.16%	1.07%	0.89%	0.66%	0.09%	0.13%	0.34%	0.62%	0.91%

Balance Sheet

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	3.50B	3.42B	3.47B	5.46B	5.73B	6.01B	5.91B	5.74B	5.21B
Total Liabilities	2.79B	2.58B	2.34B	1.87B	1.80B	2.01B	2.31B	2.15B	1.77B
Total Equity	705.59M	835.54M	1.12B	3.58B	3.92B	3.99B	3.59B	3.58B	3.32B
Cash	792.36M	301.63M	394.75M	2.53B	2.44B	1.66B	1.48B	1.33B	1.02B
Total Debt	852.96M	466.47M	524.38M	201.61M	37.55M	277.75M	462.91M	644.40M	738.30M
Net Debt	60.60M	164.84M	129.63M	-2.33B	-2.40B	-1.38B	-1.02B	-687.39M	-282.29M

Cash Flow

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	214.81M	192.70M	324.94M	697.66M	515.24M	-121.17M	785.49M	438.24M	344.00M
Investing Cash Flow	471.52M	-24.50M	-179.57M	-190.72M	-200.84M	-556.54M	-502.05M	-545.76M	-473.28M
Financing Cash Flow	-501.60M	-420.58M	-7.74M	1.64B	-408.28M	-101.60M	-432.19M	-28.46M	-112.15M
Capital Expenditure	105.28M	173.83M	148.01M	126.72M	200.49M	547.96M	497.48M	358.60M	135.08M
Free Cash Flow	109.52M	18.87M	176.93M	570.94M	314.75M	-669.13M	288.01M	79.64M	208.92M
Dividends Paid	392.48M	31.08M	25.76M	22.18M	202.50M	306.00M	495.00M	111.25M	23.24M
FCF to OCF	50.99%	9.79%	54.45%	81.84%	61.09%	552.23%	36.67%	18.17%	60.73%
Dividend Paid to FCF	358.35%	164.71%	14.56%	3.88%	64.34%	-45.73%	171.87%	139.69%	11.13%

Earnings

Report Date	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Apr 28, 2022	Aug 25, 2022	Oct 28, 2022	Feb 27, 2023	Apr 27, 2023	Aug 17, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.42	0.16	0.32	0.36	0.38	0.14	0.17	0.43	-0.00	0.19	0.27
Surprise	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	After-hours	Pre-market	After-hours	After-hours	Pre-market	After-hours

Key Statistics & Ratios

Market Cap6.32B

Enterprise Value5.49B

Trailing P/E0.00

Forward P/E0.00

Price / Sales2.57

Price / Book1.93

EPS-0.61

Book Value7.22

Revenue (TTM)2.46B

Gross Profit (TTM)1.27B

EBITDA6.61M

Profit Margin-10.91%

Operating Margin-4.63%

Return on Equity-8.79%

Return on Assets-2.27%

Shares Outstanding450.00M

Shares Float261.63M

Beta0.64

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20241×

0.20Jun 25, 2024

20231×

1.10Jun 6, 2023

20221×

0.68Jul 15, 2022

20211×

0.45May 26, 2021